Aerocrine: BlueCross BlueShield of Florida Continues Trend, Retires Negative … – Business Wire (press release)

Aerocrine: BlueCross BlueShield of Florida Continues Trend, Retires Negative
Business Wire (press release)
We will be better able to identify patients who will respond to inhaled corticosteroids and even determine in whom we may be able to decrease the doses of asthma controller medications” Aerocrine AB (NASDAQ OMX NORDIC: AERO)(STO:AEROB) announces that

and more »

View full post on asthma – Google News

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.